FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111736005> ?p ?o ?g. }

• W3111736005 endingPage "418" @default.
• W3111736005 startingPage "389" @default.
• W3111736005 abstract "Current guidelines recommend adding an oral antihyperglycemic agent (AHA) to metformin in patients with type 2 diabetes mellitus (T2DM) uncontrolled on metformin. Recent randomized clinical trials (RCTs) have demonstrated that adding dual AHAs instead of a single AHA provided more effective glycemic control. However, the comparative efficacy of approved single and dual initiation strategies is unknown. Therefore, we conducted a Bayesian network meta-analysis to compare the efficacy of dual and single add-on oral AHAs in patients uncontrolled on metformin.A systematic literature review of RCTs was conducted following Cochrane and ISPOR guidelines. MEDLINE, Embase, and CENTRAL were searched from inception to November 19, 2019. Approved oral doses of sodium-glucose co-transporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists in single or dual initiation therapies were indirectly compared. Outcomes focused on efficacy and included mean change from baseline in hemoglobin A1c (HbA1c), weight, systolic blood pressure (SBP), diastolic blood pressure, and achieving HbA1c target < 7% at 24-26 weeks. Fixed and random effects models with Markov chain Monte Carlo simulations were used.Of 1955 unique records screened, 25 RCTs (14,264 participants) were included. In patients uncontrolled on metformin, dual AHA added to metformin had statistically significant or a trend of greater reduction in HbA1c compared to single AHAs, with ertugliflozin + sitagliptin showing the greatest improvement. Statistically significant reductions in weight and SBP were observed with ertugliflozin + sitagliptin, ertugliflozin, or canagliflozin compared to single initiation DPP-4 inhibitors.For reduction of HbA1c, weight, and SBP in patients uncontrolled on metformin, add-on dual AHAs showed greater improvement compared to single AHAs. These findings can further inform the treatment of T2DM patients uncontrolled on metformin." @default.
• W3111736005 created "2020-12-21" @default.
• W3111736005 creator A5024658365 @default.
• W3111736005 creator A5038322806 @default.
• W3111736005 creator A5039201527 @default.
• W3111736005 creator A5048853751 @default.
• W3111736005 creator A5053701021 @default.
• W3111736005 creator A5064866753 @default.
• W3111736005 creator A5069708457 @default.
• W3111736005 creator A5074688775 @default.
• W3111736005 creator A5088322790 @default.
• W3111736005 creator A5091743333 @default.
• W3111736005 date "2020-12-12" @default.
• W3111736005 modified "2023-10-10" @default.
• W3111736005 title "Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis" @default.
• W3111736005 cites W1490158739 @default.
• W3111736005 cites W1546635462 @default.
• W3111736005 cites W1975588287 @default.
• W3111736005 cites W2030311010 @default.
• W3111736005 cites W2033331104 @default.
• W3111736005 cites W2033768383 @default.
• W3111736005 cites W2058473208 @default.
• W3111736005 cites W2059439623 @default.
• W3111736005 cites W2074142099 @default.
• W3111736005 cites W2081947250 @default.
• W3111736005 cites W2101246901 @default.
• W3111736005 cites W2101374656 @default.
• W3111736005 cites W2103058881 @default.
• W3111736005 cites W2122077393 @default.
• W3111736005 cites W2125776201 @default.
• W3111736005 cites W2127622911 @default.
• W3111736005 cites W2134652590 @default.
• W3111736005 cites W2141946042 @default.
• W3111736005 cites W2158104164 @default.
• W3111736005 cites W2161852973 @default.
• W3111736005 cites W2167245776 @default.
• W3111736005 cites W2168926920 @default.
• W3111736005 cites W2171512247 @default.
• W3111736005 cites W2177336327 @default.
• W3111736005 cites W2491672698 @default.
• W3111736005 cites W2507901651 @default.
• W3111736005 cites W2588441560 @default.
• W3111736005 cites W2752384709 @default.
• W3111736005 cites W2776047972 @default.
• W3111736005 cites W2777413433 @default.
• W3111736005 cites W2787359140 @default.
• W3111736005 cites W2810092615 @default.
• W3111736005 cites W2886570623 @default.
• W3111736005 cites W2894993577 @default.
• W3111736005 cites W2897247590 @default.
• W3111736005 cites W2902165101 @default.
• W3111736005 cites W2913924631 @default.
• W3111736005 cites W2918296699 @default.
• W3111736005 cites W2946852000 @default.
• W3111736005 cites W2970684805 @default.
• W3111736005 cites W2974621372 @default.
• W3111736005 cites W2982577721 @default.
• W3111736005 cites W4245818898 @default.
• W3111736005 cites W4253996779 @default.
• W3111736005 doi "https://doi.org/10.1007/s13300-020-00975-y" @default.
• W3111736005 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7843850" @default.
• W3111736005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33313996" @default.
• W3111736005 hasPublicationYear "2020" @default.
• W3111736005 type Work @default.
• W3111736005 sameAs 3111736005 @default.
• W3111736005 citedByCount "4" @default.
• W3111736005 countsByYear W31117360052021 @default.
• W3111736005 countsByYear W31117360052023 @default.
• W3111736005 crossrefType "journal-article" @default.
• W3111736005 hasAuthorship W3111736005A5024658365 @default.
• W3111736005 hasAuthorship W3111736005A5038322806 @default.
• W3111736005 hasAuthorship W3111736005A5039201527 @default.
• W3111736005 hasAuthorship W3111736005A5048853751 @default.
• W3111736005 hasAuthorship W3111736005A5053701021 @default.
• W3111736005 hasAuthorship W3111736005A5064866753 @default.
• W3111736005 hasAuthorship W3111736005A5069708457 @default.
• W3111736005 hasAuthorship W3111736005A5074688775 @default.
• W3111736005 hasAuthorship W3111736005A5088322790 @default.
• W3111736005 hasAuthorship W3111736005A5091743333 @default.
• W3111736005 hasBestOaLocation W31117360051 @default.
• W3111736005 hasConcept C126322002 @default.
• W3111736005 hasConcept C134018914 @default.
• W3111736005 hasConcept C168563851 @default.
• W3111736005 hasConcept C2777180221 @default.
• W3111736005 hasConcept C2777451236 @default.
• W3111736005 hasConcept C2779284873 @default.
• W3111736005 hasConcept C2779306644 @default.
• W3111736005 hasConcept C2780323712 @default.
• W3111736005 hasConcept C2780473172 @default.
• W3111736005 hasConcept C555293320 @default.
• W3111736005 hasConcept C71924100 @default.
• W3111736005 hasConcept C98274493 @default.
• W3111736005 hasConceptScore W3111736005C126322002 @default.
• W3111736005 hasConceptScore W3111736005C134018914 @default.
• W3111736005 hasConceptScore W3111736005C168563851 @default.
• W3111736005 hasConceptScore W3111736005C2777180221 @default.
• W3111736005 hasConceptScore W3111736005C2777451236 @default.
• W3111736005 hasConceptScore W3111736005C2779284873 @default.

• next